Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KIRA6 is an effective inhibitor of IRE1α RNase kinase (IC50: 0.6 μM). It can trigger an apoptotic response.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 39.00 | |
2 mg | In stock | $ 54.00 | |
5 mg | In stock | $ 91.00 | |
10 mg | In stock | $ 140.00 | |
25 mg | In stock | $ 286.00 | |
50 mg | In stock | $ 413.00 | |
100 mg | In stock | $ 615.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 109.00 |
Description | KIRA6 is an effective inhibitor of IRE1α RNase kinase (IC50: 0.6 μM). It can trigger an apoptotic response. |
Targets&IC50 | IRE1α:0.6 µM (cell free) |
In vitro | KIRA6 (10-1000 nM, 72 hours) strongly compromises the viability of the KIT-dependent cell line HMC-1.1 at the low nM concentration, in a manner that coincided with KIT blockade. KIRA6 (1nM-100μM) bounds to the cytoplasmic domain of KIT with a Kd value of 10.8 ?μM. KIRA6 (10-1000 nM, 1 hour) reduces signaling output of KIT, including the phosphorylation of KIT as well as its downstream signaling modules, PSTAT5 and phosphorylated ERK1/2 [1]. KIRA6 (1 μM, 0-48 hours) inhibits Ins1 mRNA decay from IRE1α hyperactivation in a dose-dependent manner. KIRA6 (0.1-10μM, 72 hours) dose-dependently reduces 1NM-PP1 potentiation of Ins1 apoptosis during ER stress in a dose-dependent manner [2]. |
In vivo | KIRA6 (intraperitoneal injection; 5 mg/kg; 37 days) shows significant amelioration of random glucose levels over several weeks compared to the vehicle, both fed ad lib. KIRA6 (i.p, 5 mg/kg, 21 or 18 days post injections) increases both plasma insulin and C-peptide levels, remains insulin-positive islet areas at a high level after stopping injections in the Akita Mouse [2]. |
Cell Research | Cell Line: HMC-1.1 cells. Concentration: 10 nM, 30 nM, 100 nM, 300 nM, 1000 nM. Incubation Time: 72 hours [1] |
Animal Research | Animal Model: Male Ins2+/Akita mice. Dosage: 5 mg/kg. Administration: Intraperitoneal injection, 5 mg/kg, 21 or 18 days post injections [2] |
Molecular Weight | 518.53 |
Formula | C28H25F3N6O |
CAS No. | 1589527-65-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 2 mg/mL (3.86 mM), Sonification is recommended.
DMSO: 5 mg/mL (9.64 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KIRA6 1589527-65-0 Cell Cycle/Checkpoint IRE1 Inhibitor KIRA 6 Inositol requiring enzyme 1 inhibit KIRA-6 inhibitor